Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study

Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lucia Caminiti (Autor), Francesca Galletta (Autor), Simone Foti Randazzese (Autor), Paolo Barraco (Autor), Stefano Passanisi (Autor), Antonella Gambadauro (Autor), Giuseppe Crisafulli (Autor), Mariella Valenzise (Autor), Sara Manti (Autor)
Formato: Libro
Publicado: MDPI AG, 2024-01-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible